Tramadol chemical structure
Find information on thousands of medical conditions and prescription drugs.

Ultram


Tramadol is an opioid used as an analgesic for treating moderate to severe pain. It is a synthetic agent, unrelated to other opioids, and appears to have actions on the GABAergic, noradrenergic and serotonergic systems. Tramadol was developed by the German pharmaceutical company Grünenthal GmbH and marketed under the trade name Tramal®. Grünenthal has also cross licensed the drug to many other pharmaceutical companies that market it under various names, some of which are listed below. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
Ubidecarenone
Ultram
Unasyn
Unipen
Uniphyl
Unisom
Urethane
Urofollitropin
Urokinase
Uroxatral
Ursodeoxycholic acid
V
W
X
Y
Z

Tramadol is available in both injectable (intravenous and/or intramuscular) and oral preparations. It is usually marketed as the hydrochloride salt (tramadol hydrochloride). Dosages vary depending on the degree of pain experienced by the patient, and should be decided on the basis of need by the prescriber.

Mechanism of action

The mechanism of action of tramadol has yet to be fully elucidated, but it is believed to work through modulation of the GABAergic, noradrenergic and serotonergic systems. Tramadol have been found to bind to μ-opioid receptors (thus exerting its effect on GABAergic transmission), and to inhibit reuptake of 5-HT and noradrenaline. The second mechanism is believed to contribute since the analgesic effects of tramadol are not fully antagonised by the μ-opioid receptor antagonist naloxone.

Although irrelevant to its mechanism of action, tramadol, unlike morphine, has not been found to induce histamine release.

The serotonergic modulating properties of tramadol mean that it has the potential to interact with other serotonergic agents. There is an increased risk of serotonin syndrome when tramadol is taken in combination with reuptake inhibitors (e.g. SSRIs), agents that potentiate the effect of 5-HT (e.g., MAOIs), or 5-HT agonists.

Dependence

Some controversy exists regarding the dependence liability of tramadol. Grünenthal has promoted it as an opioid with "little" risk of dependence, claiming little evidence of such dependence in their clinical trials. They offer the theory that since the M1 metabolite is the principal agonist at μ-opioid receptors, the delayed agonist activity reduces dependence liability.

Despite these claims it is apparent, in community practice, that dependence does occur to this agent. This would be expected since analgesic and dependence effects are mediated by the same μ-opioid receptor. However, this dependence liability is considered relatively low by health authorities, such that tramadol is classified as a Schedule 4 in Australia, rather than as a Schedule 8 like other opioids (Rossi, 2004).

Proprietary preparations

Grünenthal, which still owns the patent to tramadol, has cross-licensed the agent to various pharmaceutical companies internationally. Thus tramadol is marketed under many trade names including: Adolonta, Contramal, Crispin, Nobligan, Siverol, Tiparol, Toplagic, Tradolan, Tralgit, Tramacet, Tramadin, Ultracet, Ultram, Zamadol and Zydol.

Read more at Wikipedia.org


[List your site here Free!]


Ultram - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References $28.95

Take back your energy: here are 31 ways to control the pain and exhaustion of fibromyalgia
AS A KID, Lynne Matallana recalls telling her mother she hurt--a lot. "I was told to rise above it," she says. She tried but wasn't always ...
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Chronic Pain
One Woman's Experience with Intractable Nonmalignant Chronic Pain -An Interview with Patient Karen Balzer One prescription for the proper compounded medicine ...
Materials of the Pennsylvania German fraktur artist
In 1897 Henry Chapman Mercer (1856-1930) delivered a lecture to the American Philosophical Society in Philadelphia entitled "The Survival of the Mediaeval Art of Illuminative Writing among P
Chronic pain management in older adults: with coxibs under fire, what now?
Chronic non-cancer pain is notoriously undertreated, especially when the source cannot be identified by objective testing. Effective treatment often requires a combination of pharmacologic and non-p
Oral analgesics for acute nonspecific pain
Physicians most often recommend or prescribe oral medication for relief of acute pain. This review of the available evidence supports the use of acetaminophen ...
Useful treatments for fibromyalgia syndrome
CLINICAL QUESTION What treatment modalities are most effective for fibromyalgia syndrome? * BOTTOM LINE Treatments for fibromyalgia syndrome ...
What is the addiction risk associated with tramadol?
EVIDENCE-BASED ANSWER Tramadol (Ultram, generic and with acetaminophen in Ultracet) carries a risk of substance abuse (strength of recommendation ...
Reactions, misuse with pain medication - new labeling for Ultram, or tramadol - Brief Article
Reports of serious adverse reactions and potential misuse have led to revised labeling for the prescription pain reliever Ultram (tramadol). FDA also has sent a letter to health-care professionals on

Home Contact Resources Exchange Links ebay